Paradromics is creating a future where direct data interfaces with the brain unlock technology solutions to unmet medical challenges. A revolutionary leap beyond today’s lab-confined brain-computer interfaces (BCI), our Connexus™ Direct Data Interface (DDI) collects an unprecedented number of individual neural signals with a fully-implantable device designed for long-term daily service. Our first clinical application is an assistive communication device for patients who’ve lost the physical ability to speak or type. The Connexus DDI platform has boundless potential for future applications, from enabling people with sensory and motor impairment to treating neuropsychiatric disorders. An Austin-based medical technology company, Paradromics was founded in 2015 and has raised $38M in venture funding and received $18M in non-dilutive public funding (DARPA and NIH).
Is this your company?
Inaccurate data? Flag it here.